398 related articles for article (PubMed ID: 19491669)
61. High-dose chemotherapy followed by autologous stem-cell transplantation in liver-transplanted multiple myeloma patients: a report of two cases.
Peterlin P; Gastinne T; Moreau P; Harousseau JL; Le Gouill S
Transplantation; 2009 Feb; 87(4):617-8. PubMed ID: 19307803
[No Abstract] [Full Text] [Related]
62. Autologous stem cell transplantation for multiple myeloma in the era of novel agents.
Shimazaki C
Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):14-5. PubMed ID: 24461805
[No Abstract] [Full Text] [Related]
63. Strategies in treating newly diagnosed or untreated multiple myeloma patients. From the Multiple Myeloma Research Foundation.
Weber DM
Oncology (Williston Park); 2003 Jun; 17(6):765-7. PubMed ID: 12846120
[TBL] [Abstract][Full Text] [Related]
64. Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen.
Berenson JR; Yellin O; Woytowitz D; Flam MS; Cartmell A; Patel R; Duvivier H; Nassir Y; Eades B; Abaya CD; Hilger J; Swift RA
Eur J Haematol; 2009 Jun; 82(6):433-9. PubMed ID: 19226361
[TBL] [Abstract][Full Text] [Related]
65. New questions about transplantation in multiple myeloma.
Hari P; Pasquini MC; Vesole DH
Oncology (Williston Park); 2006 Sep; 20(10):1230-42; discussion 1242, 1244, 1249-50. PubMed ID: 17024872
[TBL] [Abstract][Full Text] [Related]
66. Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma.
Hequet O; Dumontet C; El Jaafari-Corbin A; Salles G; Espinouse D; Arnaud P; Thieblemont C; Bouafia F; Coiffier B
Bone Marrow Transplant; 2002 Mar; 29(6):544. PubMed ID: 11960281
[No Abstract] [Full Text] [Related]
67. The changing treatment paradigm in patients with newly diagnosed multiple myeloma: implications for nursing.
Tariman JD; Estrella SM
Oncol Nurs Forum; 2005 Nov; 32(6):E127-38. PubMed ID: 16270103
[TBL] [Abstract][Full Text] [Related]
68. Presentation and risk stratification--improving prognosis for patients with multiple myeloma.
Lonial S
Cancer Treat Rev; 2010 May; 36 Suppl 2():S12-7. PubMed ID: 20472183
[TBL] [Abstract][Full Text] [Related]
69. Clinical significance of cyclin D1, fibroblast growth factor receptor 3, and p53 immunohistochemistry in plasma cell myeloma treated with a thalidomide-based regimen.
Kelley TW; Baz R; Hussein M; Karafa M; Cook JR
Hum Pathol; 2009 Mar; 40(3):405-12. PubMed ID: 19070887
[TBL] [Abstract][Full Text] [Related]
70. BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma.
Talamo G; Claxton DF; Dougherty DW; Ehmann CW; Sivik J; Drabick JJ; Rybka W
Bone Marrow Transplant; 2009 Aug; 44(3):157-61. PubMed ID: 19204716
[TBL] [Abstract][Full Text] [Related]
71. [Single vs double stem cell transplantation for the treatment of multiple myeloma].
Tamura H
Nihon Rinsho; 2015 Jan; 73(1):85-9. PubMed ID: 25626310
[TBL] [Abstract][Full Text] [Related]
72. Lenalidomide: a new therapy for multiple myeloma.
Palumbo A; Miguel JS; Sonneveld P; Moreau P; Drach J; Morgan G; Einsele H
Cancer Treat Rev; 2008 May; 34(3):283-91. PubMed ID: 18230411
[TBL] [Abstract][Full Text] [Related]
73. The role of high-dose therapy with autologous stem cell support in the era of novel agents.
Attal M; Harousseau JL
Semin Hematol; 2009 Apr; 46(2):127-32. PubMed ID: 19389496
[TBL] [Abstract][Full Text] [Related]
74. Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.
Dimopoulos MA; Kastritis E; Delimpasi S; Katodritou E; Hatzimichael E; Kyrtsonis MC; Repousis P; Tsirogianni M; Kartasis Z; Parcharidou A; Michael M; Michalis E; Tsatalas C; Stefanoudaki E; Hatjiharissi E; Gika D; Symeonidis A; Terpos E; Zervas K;
Eur J Haematol; 2012 Jul; 89(1):10-5. PubMed ID: 22469521
[TBL] [Abstract][Full Text] [Related]
75. Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma.
Palumbo A; Dimopoulos M; San Miguel J; Harousseau JL; Attal M; Hussein M; Knop S; Ludwig H; von Lilienfeld-Toal M; Sonneveld P
Blood Rev; 2009 Mar; 23(2):87-93. PubMed ID: 18774632
[TBL] [Abstract][Full Text] [Related]
76. Have drug combinations supplanted stem cell transplantation in myeloma?
Palumbo A; Cavallo F
Blood; 2012 Dec; 120(24):4692-8. PubMed ID: 22730541
[TBL] [Abstract][Full Text] [Related]
77. Salvage therapy in Hodgkin's lymphoma.
Mendler JH; Friedberg JW
Oncologist; 2009 Apr; 14(4):425-32. PubMed ID: 19342476
[TBL] [Abstract][Full Text] [Related]
78. Role of allogeneic stem cell transplantation in multiple myeloma.
Bruno B; Giaccone L; Sorasio R; Boccadoro M
Semin Hematol; 2009 Apr; 46(2):158-65. PubMed ID: 19389499
[TBL] [Abstract][Full Text] [Related]
79. [Treatment for multiple myeloma: current status and future strategy in Japan].
Iida S
Rinsho Ketsueki; 2008 Oct; 49(10):1368-73. PubMed ID: 18833921
[No Abstract] [Full Text] [Related]
80. Recent phase III trials in the frontline treatment of multiple myeloma: evaluating their impact on community practice.
SanMiguel J; Facon T; Cavo M
Clin Adv Hematol Oncol; 2008 Apr; 6(4):s4-s10. PubMed ID: 18567204
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
